Sex differences in pain, inflammation and Alzheimer's disease

New evidence supports the idea that differences within and between sexes impact how neurological disorders progress and respond to treatment. The findings were presented at Neuroscience 2026, the annual meeting of the Society ...

New biomarkers for Alzheimer's disease, depression and beyond

Newly developed biomarkers may enhance clinicians' ability to detect and treat disorders of the nervous system, including Alzheimer's disease, mood disorders and neurodevelopmental conditions. The findings were presented ...

page 13 from 40